Nov 26 (Reuters) - Aroa Biosurgery Ltd ARX.AX:
ANTICIPATES H2 FY25 TOTAL REVENUE OF NZ$43-$50 MILLION
EXPECTS H2 FY24 NORMALISED EBITDA PROFIT OF NZ$4-8 MLN
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Nov 26 (Reuters) - Aroa Biosurgery Ltd ARX.AX:
ANTICIPATES H2 FY25 TOTAL REVENUE OF NZ$43-$50 MILLION
EXPECTS H2 FY24 NORMALISED EBITDA PROFIT OF NZ$4-8 MLN
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Comments